Neuralink vs Synchron
October 12, 2025
Neuralink and Synchron are both startups developing brain-computer interfaces (BCIs). They use minimally invasive methods compared to earlier BCIs and focus on clinical applications for people with paralysis and amyotrophic lateral sclerosis (for letting them control devices with thought power). Both startups have received FDA approval and are conducting animal and human trials.
But Neuralink (founded in 2016) is an American startup founded by Elon Musk. It uses a robotic system to precisely implant electrodes directly into the brain. Their main product - N1 implant has thousands of electrodes that ensure high bandwidth bidirectional communication between the chip and the brain. The first clinical surgery on a human was conducted in 2024.
Synchron (2012) is an Australian startup that installs its Stentrode implant through blood vessels without opening the skull. It has fewer electrodes and enables the link only in one direction - from the brain to the computer, but it's safer and compatible with existing medical technologies. The first successful human use was in 2019.
But Neuralink (founded in 2016) is an American startup founded by Elon Musk. It uses a robotic system to precisely implant electrodes directly into the brain. Their main product - N1 implant has thousands of electrodes that ensure high bandwidth bidirectional communication between the chip and the brain. The first clinical surgery on a human was conducted in 2024.
Synchron (2012) is an Australian startup that installs its Stentrode implant through blood vessels without opening the skull. It has fewer electrodes and enables the link only in one direction - from the brain to the computer, but it's safer and compatible with existing medical technologies. The first successful human use was in 2019.
★
See also:
